CONTACT: RACHEL BALLWEG
8788 John Pappajohn Pavilion
Iowa City IA 52242
Release: Feb. 6, 2001
UI Adult Blood and Marrow Transplantation Program earns accreditation
IOWA CITY, Iowa -- The Holden Comprehensive Cancer Center Adult Blood and
Marrow Transplantation Program, along with the Hemopoietic Progenitor Cell
Laboratory and the Therapeutic Apheresis Service of the DeGowin Blood Center
at the University of Iowa Hospitals and Clinics, recently received accreditation
from the Foundation for the Accreditation of Hemopoietic Cell Therapy (FAHCT).
The FAHCT is a nonprofit agency created in 1994 by the International Society
of Hemotherapy and Graft Engineering and the American Society of Blood and
Marrow Transplantation. Its goal is to ensure that patients receiving blood
and marrow stem cell transplants would be cared for at centers providing the
highest quality care backed by ongoing research and educational programs.
The Holden Comprehensive Cancer Center Adult Blood and Marrow Transplantation
Program is one of 61 accredited centers nationwide and one of four in the
states that border Iowa.
"Our program is honored by this accreditation," said Roger Gingrich,
M.D., UI professor of internal medicine and associate director of clinical
services at the Holden Comprehensive Cancer Center. "But at the same
time we recognize the obligation and challenge to continue to provide high
quality care in a research environment."
University of Iowa Health Care describes the partnership between
the UI College of Medicine and the UI Hospitals and Clinics and the patient
care, medical education and research programs and services they provide.